{"DataElement":{"publicId":"6028366","version":"1","preferredName":"Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Clinical T Stage","preferredDefinition":"A response used to determine the extent of tumor involvement at the primary site of a rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses.","longName":"6028241v1.0:6028242v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6028241","version":"1","preferredName":"Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Clinical T Stage","preferredDefinition":"A rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses.  It affects most often the maxillary sinus.  Less frequently, it arises from the nasal cavity, ethmoid sinus, sphenoid sinus, and frontal sinus.  Symptoms include nasal fullness, epistaxis, rhinorhea, pain, and paresthesia.  Patients with nasal squamous cell carcinoma usually present earlier than patients with maxillary sinus carcinoma and have a better prognosis compared to the latter group._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"6028239v1.0:2207100v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"6028239","version":"1","preferredName":"Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma","preferredDefinition":"A rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses.  It affects most often the maxillary sinus.  Less frequently, it arises from the nasal cavity, ethmoid sinus, sphenoid sinus, and frontal sinus.  Symptoms include nasal fullness, epistaxis, rhinorhea, pain, and paresthesia.  Patients with nasal squamous cell carcinoma usually present earlier than patients with maxillary sinus carcinoma and have a better prognosis compared to the latter group.","longName":"C68611","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Squamous Cell Carcinoma","conceptCode":"C68611","definition":"A rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses.  It affects most often the maxillary sinus.  Less frequently, it arises from the nasal cavity, ethmoid sinus, sphenoid sinus, and frontal sinus.  Symptoms include nasal fullness, epistaxis, rhinorhea, pain, and paresthesia.  Patients with nasal squamous cell carcinoma usually present earlier than patients with maxillary sinus carcinoma and have a better prognosis compared to the latter group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E0708A7-7812-671A-E053-F662850A9531","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E0708A7-7820-671A-E053-F662850A9531","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeDescription":"Created for EA3163, 11/15/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6028242","version":"1","preferredName":"NPNSCC Clinical T Stage","preferredDefinition":"The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6028242v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T3","valueDescription":"T3 Stage Finding","ValueMeaning":{"publicId":"3201433","version":"1","preferredName":"T3 Stage Finding","longName":"3201433","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3 TNM Finding","conceptCode":"C48728","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3D7B-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B22D-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"T4b","valueDescription":"T4b Stage Finding","ValueMeaning":{"publicId":"3201439","version":"1","preferredName":"T4b Stage Finding","longName":"3201439","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4b TNM Finding","conceptCode":"C48734","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E57-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B219-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"T4a","valueDescription":"T4a Stage Finding","ValueMeaning":{"publicId":"3370612","version":"1","preferredName":"T4a Stage Finding","longName":"3370612","preferredDefinition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4a TNM Finding","conceptCode":"C48733","definition":"A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4a TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the prostatic stroma, uterus, and vagina; for gastric cancer it refers to a primary tumor that invades the serosa (visceral peritoneum); for colorectal cancer it refers to a primary tumor that penetrates to the surface of the visceral peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B84DB87E-EC22-21D4-E040-BB89AD436BB9","latestVersionIndicator":"Yes","beginDate":"2012-02-06","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-02-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B223-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"T2","valueDescription":"T2 Stage Finding","ValueMeaning":{"publicId":"3201429","version":"1","preferredName":"T2 Stage Finding","longName":"3201429","preferredDefinition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3CE9-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B237-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"T1","valueDescription":"T1 Stage Finding","ValueMeaning":{"publicId":"3687408","version":"1","preferredName":"T1 Stage Finding","longName":"3687408","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5CA35AA-9F9B-FFA5-E040-BB89AD435F4C","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"PATELV","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B241-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Tis Stage Finding","ValueMeaning":{"publicId":"3201442","version":"1","preferredName":"Breast Cancer pTis TNM Finding v6 and v7","longName":"3201442v1.00","preferredDefinition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EC4-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B24B-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"T0","valueDescription":"T0 Stage Finding","ValueMeaning":{"publicId":"3201423","version":"1","preferredName":"T0 Stage Finding","longName":"3201423","preferredDefinition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T0 TNM Finding","conceptCode":"C48719","definition":"A primary tumor TNM finding indicating that there is no evidence of primary tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3C0F-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"ONEDATA","dateModified":"2011-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B255-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"TX","valueDescription":"TX Stage Finding","ValueMeaning":{"publicId":"3201443","version":"1","preferredName":"TX Stage Finding","longName":"3201443","preferredDefinition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EE7-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E0739D8-B25F-223E-E053-F662850A0DF2","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E0739D8-B200-223E-E053-F662850A0DF2","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeDescription":"Created for EA3163, 11/15/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"3852732","version":"1","longName":"Disease Site","context":"ECOG-ACRIN"},{"publicId":"10000047","version":"1","longName":"Pathology","context":"ECOG-ACRIN"},{"publicId":"3314470","version":"1","longName":"Head/Neck/Neuro","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"NPNSCC T Stage","type":"Preferred Question Text","description":"NPNSCC T Stage","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E075625-B5F0-22A1-E053-F662850A26A9","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-11-15","modifiedBy":"GARRIDOJ","dateModified":"2018-02-28","changeDescription":"Created for EA3163, 11/15/2017 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}